The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Seagen Inc.
Jazz Pharmaceuticals
Seagen Inc.
Yonsei University
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)